dolutegravir lamivudine and Tenofovir Disoproxil Fumarate Tablets IP

dolutegravir lamivudine and Tenofovir Disoproxil Fumarate Tablets IP

Product Details:

  • Origin of Medicine Allopathic
  • Salt Composition Dolutegravir Sodium Lamivudine Tenofovir Disoproxil Fumarate
  • Pacakaging (Quantity Per Box) 1 bottle containing 30 tablets
  • Drug Type Antiretroviral
  • Ingredients Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate
  • Physical Form Tablet
  • Function Treatment of HIV-1 infection
  • Click to View more
X

dolutegravir lamivudine and Tenofovir Disoproxil Fumarate Tablets IP Product Specifications

  • Treatment of HIV-1 infection
  • Dolutegravir Sodium Lamivudine Tenofovir Disoproxil Fumarate
  • Adults and adolescents aged 12 years and older weighing at least 35 kg
  • As prescribed by a healthcare professional
  • 1 bottle containing 30 tablets
  • Typically taken once daily with or without food
  • Dolutegravir Lamivudine Tenofovir Disoproxil Fumarate
  • Tablet
  • Store below 30C in a dry place away from direct sunlight
  • Allopathic
  • Antiretroviral
  • Patients living with HIV-1
  • 30 tablets per bottle

Product Description



These Dolutegravir Lamivudine and Tenofovir Disoproxil Fumarate Tablets IP are typically taken once daily with or without food for the treatment of HIV-1 infection. Each bottle contains 30 tablets, with the active ingredients being Dolutegravir Sodium, Lamivudine, and Tenofovir Disoproxil Fumarate. These tablets are suitable for adults and adolescents aged 12 years and older weighing at least 35 kg. They are antiretroviral drugs that must be taken as prescribed by a healthcare professional. The medicine should be stored below 30C in a dry place away from direct sunlight.

FAQs of dolutegravir lamivudine and Tenofovir Disoproxil Fumarate Tablets IP:


Q: What is the recommended dosage for these tablets?

A: The recommended dosage is typically once daily, as prescribed by a healthcare professional.

Q: What is the function of these tablets?

A: These tablets are used for the treatment of HIV-1 infection.

Q: Who are these tablets recommended for?

A: These tablets are recommended for patients living with HIV-1.

Q: What is the packaging quantity for these tablets?

A: Each bottle contains 30 tablets.

Q: What is the age group these tablets are suitable for?

A: These tablets are suitable for adults and adolescents aged 12 years and older weighing at least 35 kg.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Tablets' category



"We are accepting bulk order only."

Back to top